Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Head & Neck 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Urogenital Neoplasms 1Sarcoma 1Neoplasms 1Melanoma 1Lung Neoplasms 1Hypertension 1Head and Neck Neoplasms 1Diabetes Mellitus 1Depressive Disorder, Major 1Depression 1Colorectal Neoplasms 1Cardiovascular Diseases 1Breast Neoplasms 1

Interventions

pembrolizumab 6Cisplatin 5Radiotherapy 3Radiotherapy, Intensity-Modulated 2Paclitaxel 2Fluorouracil 2Docetaxel 2ponatinib 1cyclopropapyrroloindole 1bempegaldesleukin 1alovudine 1Thioctic Acid 1Sonazoid 1Radiation 1Pilocarpine 1Gemcitabine 1Fluconazole 1Fatty Acids, Omega-3 1Exercise 1Erlotinib Hydrochloride 1Drug Therapy 1Carboplatin 1Atorvastatin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Head and Neck Neoplasms × Fatty Acids, Omega-3 × Clear all
NCT01259284 2012-08-07

Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer

M.D. Anderson Cancer Center

Phase 2/3 Terminated
2 enrolled 4 charts
BreastDermatologicGastrointestinalHead & NeckSarcomaThoracic

Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Sarcoma, Urogenital Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡